190 related articles for article (PubMed ID: 34289895)
1. Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions.
Wisse LEM; Ravikumar S; Ittyerah R; Lim S; Lane J; Bedard ML; Xie L; Das SR; Schuck T; Grossman M; Lee EB; Tisdall MD; Prabhakaran K; Detre JA; Mizsei G; Trojanowski JQ; Artacho-Pérula E; de Iñiguez de Onzono Martin MM; M Arroyo-Jiménez M; Muñoz Lopez M; Molina Romero FJ; P Marcos Rabal M; Cebada Sánchez S; Delgado González JC; de la Rosa Prieto C; Córcoles Parada M; Wolk DA; Irwin DJ; Insausti R; Yushkevich PA
Acta Neuropathol Commun; 2021 Jul; 9(1):128. PubMed ID: 34289895
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathology.
Ravikumar S; Wisse LEM; Lim S; Ittyerah R; Xie L; Bedard ML; Das SR; Lee EB; Tisdall MD; Prabhakaran K; Lane J; Detre JA; Mizsei G; Trojanowski JQ; Robinson JL; Schuck T; Grossman M; Artacho-Pérula E; de Onzoño Martin MMI; Del Mar Arroyo Jiménez M; Muñoz M; Romero FJM; Del Pilar Marcos Rabal M; Sánchez SC; González JCD; de la Rosa Prieto C; Parada MC; Irwin DJ; Wolk DA; Insausti R; Yushkevich PA
Acta Neuropathol Commun; 2021 Oct; 9(1):173. PubMed ID: 34689831
[TBL] [Abstract][Full Text] [Related]
3. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
[TBL] [Abstract][Full Text] [Related]
4. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.
de Flores R; Wisse LEM; Das SR; Xie L; McMillan CT; Trojanowski JQ; Robinson JL; Grossman M; Lee E; Irwin DJ; Yushkevich PA; Wolk DA
Alzheimers Dement; 2020 Jun; 16(6):843-852. PubMed ID: 32323446
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal atrophy in early Braak regions in preclinical Alzheimer's disease.
Xie L; Wisse LEM; Das SR; Vergnet N; Dong M; Ittyerah R; de Flores R; Yushkevich PA; Wolk DA;
Hum Brain Mapp; 2020 Nov; 41(16):4704-4717. PubMed ID: 32845545
[TBL] [Abstract][Full Text] [Related]
6. Pathological drivers of neurodegeneration in suspected non-Alzheimer's disease pathophysiology.
Wisse LEM; de Flores R; Xie L; Das SR; McMillan CT; Trojanowski JQ; Grossman M; Lee EB; Irwin D; Yushkevich PA; Wolk DA;
Alzheimers Res Ther; 2021 May; 13(1):100. PubMed ID: 33990226
[TBL] [Abstract][Full Text] [Related]
7. A protocol for manual segmentation of medial temporal lobe subregions in 7 Tesla MRI.
Berron D; Vieweg P; Hochkeppler A; Pluta JB; Ding SL; Maass A; Luther A; Xie L; Das SR; Wolk DA; Wolbers T; Yushkevich PA; Düzel E; Wisse LEM
Neuroimage Clin; 2017; 15():466-482. PubMed ID: 28652965
[TBL] [Abstract][Full Text] [Related]
8. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
9. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
[TBL] [Abstract][Full Text] [Related]
10. Shared vulnerability of two synaptically-connected medial temporal lobe areas to age and cognitive decline: a seven tesla magnetic resonance imaging study.
Kerchner GA; Bernstein JD; Fenesy MC; Deutsch GK; Saranathan M; Zeineh MM; Rutt BK
J Neurosci; 2013 Oct; 33(42):16666-72. PubMed ID: 24133269
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.
Ghirelli A; Tosakulwong N; Weigand SD; Clark HM; Ali F; Botha H; Duffy JR; Utianski RL; Buciuc M; Murray ME; Labuzan SA; Spychalla AJ; Pham NTT; Schwarz CG; Senjem ML; Machulda MM; Baker M; Rademakers R; Filippi M; Jack CR; Lowe VJ; Parisi JE; Dickson DW; Josephs KA; Whitwell JL
Ann Neurol; 2020 Nov; 88(5):1009-1022. PubMed ID: 32869362
[TBL] [Abstract][Full Text] [Related]
12. Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.
Bejanin A; Murray ME; Martin P; Botha H; Tosakulwong N; Schwarz CG; Senjem ML; Chételat G; Kantarci K; Jack CR; Boeve BF; Knopman DS; Petersen RC; Giannini C; Parisi JE; Dickson DW; Whitwell JL; Josephs KA
Brain; 2019 Nov; 142(11):3621-3635. PubMed ID: 31562527
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment.
Su L; Hayes L; Soteriades S; Williams G; Brain SAE; Firbank MJ; Longoni G; Arnold RJ; Rowe JB; O'Brien JT
J Alzheimers Dis; 2018; 61(1):415-424. PubMed ID: 29171994
[TBL] [Abstract][Full Text] [Related]
14. Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe.
Adams JN; Maass A; Berron D; Harrison TM; Baker SL; Thomas WP; Stanfill M; Jagust WJ
J Neurosci; 2021 Apr; 41(17):3917-3931. PubMed ID: 33731446
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.
Scarioni M; Gami-Patel P; Peeters CFW; de Koning F; Seelaar H; Mol MO; van Swieten JC; ; Rozemuller AJM; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
Brain; 2023 Jan; 146(1):307-320. PubMed ID: 35136978
[TBL] [Abstract][Full Text] [Related]
16. Tau deposition is associated with functional isolation of the hippocampus in aging.
Harrison TM; Maass A; Adams JN; Du R; Baker SL; Jagust WJ
Nat Commun; 2019 Oct; 10(1):4900. PubMed ID: 31653847
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
18. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.
Gourmaud S; Shou H; Irwin DJ; Sansalone K; Jacobs LM; Lucas TH; Marsh ED; Davis KA; Jensen FE; Talos DM
Brain; 2020 Jan; 143(1):191-209. PubMed ID: 31834353
[TBL] [Abstract][Full Text] [Related]
20. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
